Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Islet & Pancreas Transplant Archives
Print | Email | Share | Comments (0)

Dr. Soon-Shiong Sued by Mylan Laboratories


Aug 1, 1998

Dr. Soon-Shiong

Mylan Laboratories Inc. has filed suit in a Los Angeles court against Patrick Soon-Shiong, MD, the well publicized islet cell transplant researcher at VivoRX.

Mylan claimed that Soon-Shiong diverted some of the $46 million it had invested for islet cell transplant research into other non-diabetes related companies which directly profited Soon-Shiong.

According to a June 30th, Bloomberg Financial News article, the suit said the Pittsburgh based Mylan Laboratories had invested the money since 1994 to develop islet cell encapsulation research. The company learned of the wrongdoing when it saw a private placement memo in which Soon-Shiong was seeking $75 million in new investments from other parties.

Soon-Shiong is no longer at the Los Angeles based VivoRX and, he has been unavailable for comment since the suit was filed.

Patricia Sunseri, vice president of investor and public relations at Mylan Laboratories commented that the suit was against Soon-Shiong and not VivoRX.

"We'll go on with the encapsulated islet project," said Sunseri. "Right now we are evaluating how best to proceed."

George Simon, Senior director of corporate development at VivoRX says Mylan Laboratories is supportive and committed to helping VivoRx move forward. Shortly after filing the suit, Mylan Board members visited VivoRX to oversee company proceedings. Simon would not confirm if Soon-Shiong had been fired or had resigned.

Pat Ames, a VivoRX researcher said phase I trials on islet cell transplantation will continue despite Soon-Shiong's departure. The trials will use human cadaver islets and require that participants be on immunosuppressants. Currently, 150 people have applied to participate in the trial.


Categories: Diabetes, Islet & Pancreas Transplant



You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.